A study of the human pancreatic cancer cell lines SW1990 and PANC-1 [15] suggested that the binding of HGF and MET causes EMT-associated chemoresistance through its downstream PI3K/Akt pathway. The gene discussed is MET; the disease is familial pancreatic carcinoma.